1. Home
  2. NOTV vs HGBL Comparison

NOTV vs HGBL Comparison

Compare NOTV & HGBL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • HGBL
  • Stock Information
  • Founded
  • NOTV 1974
  • HGBL 1937
  • Country
  • NOTV United States
  • HGBL United States
  • Employees
  • NOTV N/A
  • HGBL N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • HGBL Business Services
  • Sector
  • NOTV Health Care
  • HGBL Consumer Discretionary
  • Exchange
  • NOTV Nasdaq
  • HGBL Nasdaq
  • Market Cap
  • NOTV 57.7M
  • HGBL 66.7M
  • IPO Year
  • NOTV 1997
  • HGBL N/A
  • Fundamental
  • Price
  • NOTV $1.69
  • HGBL $1.91
  • Analyst Decision
  • NOTV Strong Buy
  • HGBL Strong Buy
  • Analyst Count
  • NOTV 1
  • HGBL 1
  • Target Price
  • NOTV $5.00
  • HGBL $4.00
  • AVG Volume (30 Days)
  • NOTV 429.6K
  • HGBL 42.3K
  • Earning Date
  • NOTV 08-06-2025
  • HGBL 08-07-2025
  • Dividend Yield
  • NOTV N/A
  • HGBL N/A
  • EPS Growth
  • NOTV N/A
  • HGBL N/A
  • EPS
  • NOTV N/A
  • HGBL 0.10
  • Revenue
  • NOTV $505,299,000.00
  • HGBL $48,940,000.00
  • Revenue This Year
  • NOTV $5.64
  • HGBL $21.54
  • Revenue Next Year
  • NOTV $5.16
  • HGBL $4.10
  • P/E Ratio
  • NOTV N/A
  • HGBL $19.17
  • Revenue Growth
  • NOTV 0.85
  • HGBL N/A
  • 52 Week Low
  • NOTV $1.15
  • HGBL $1.52
  • 52 Week High
  • NOTV $6.48
  • HGBL $2.39
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 41.79
  • HGBL 39.69
  • Support Level
  • NOTV $1.65
  • HGBL $1.86
  • Resistance Level
  • NOTV $1.85
  • HGBL $1.98
  • Average True Range (ATR)
  • NOTV 0.13
  • HGBL 0.09
  • MACD
  • NOTV -0.01
  • HGBL 0.00
  • Stochastic Oscillator
  • NOTV 8.33
  • HGBL 61.11

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About HGBL Heritage Global Inc.

Heritage Global Inc values and monetizes industrial and financial assets by providing acquisition, disposition, valuation, and lending services for surplus and distressed assets. It aids in facilitating the economy by diverting useful industrial assets from landfills and operating a supply chain by overseeing the post-sale account activity of financial assets. The group operates in four segments namely Auction and Liquidation; Refurbishment and Resale; Brokerage and Specialty Lending. It generates maximum revenue from the Auction and Liquidation segment. The Auction and Liquidation segment, through HGP, operates as a full-service auction, appraisal, and asset advisory firm, including the acquisition of turnkey manufacturing facilities and used industrial machinery and equipment.

Share on Social Networks: